Warning: The NCBI web site requires JavaScript to function. more...
APOBEC3G encapsidation into HIV-1 virions: which RNA is it?
Strebel K, Khan MA.
Retrovirology. 2008 Jul 2;5:55.
Related citations
Characterization of APOBEC3G binding to 7SL RNA.
Bach D, Peddi S, Mangeat B, Lakkaraju A, Strub K, Trono D.
Retrovirology. 2008 Jul 2;5:54.
Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles.
Tian C, Wang T, Zhang W, Yu XF.
Nucleic Acids Res. 2007;35(21):7288-302. Epub 2007 Oct 24.
Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions.
Khan MA, Goila-Gaur R, Opi S, Miyagi E, Takeuchi H, Kao S, Strebel K.
Retrovirology. 2007 Jul 16;4:48.
7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
Wang T, Tian C, Zhang W, Luo K, Sarkis PT, Yu L, Liu B, Yu Y, Yu XF.
J Virol. 2007 Dec;81(23):13112-24. Epub 2007 Sep 19.
Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
Svarovskaia ES, Xu H, Mbisa JL, Barr R, Gorelick RJ, Ono A, Freed EO, Hu WS, Pathak VK.
J Biol Chem. 2004 Aug 20;279(34):35822-8. Epub 2004 Jun 20.
Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging.
Wang T, Tian C, Zhang W, Sarkis PT, Yu XF.
J Mol Biol. 2008 Jan 25;375(4):1098-112. Epub 2007 Nov 13.
Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.
Zhang W, Du J, Yu K, Wang T, Yong X, Yu XF.
J Virol. 2010 Dec;84(24):12903-13. Epub 2010 Oct 6.
Role of HIV-1 RNA and protein determinants for the selective packaging of spliced and unspliced viral RNA and host U6 and 7SL RNA in virus particles.
Didierlaurent L, Racine PJ, Houzet L, Chamontin C, Berkhout B, Mougel M.
Nucleic Acids Res. 2011 Nov 1;39(20):8915-27. Epub 2011 Jul 26.
Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA.
Yang B, Chen K, Zhang C, Huang S, Zhang H.
J Biol Chem. 2007 Apr 20;282(16):11667-75. Epub 2007 Feb 1.
Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization.
Khan MA, Goila-Gaur R, Kao S, Miyagi E, Walker RC Jr, Strebel K.
Retrovirology. 2009 Nov 3;6:99.
APOBEC3G incorporation into human immunodeficiency virus type 1 particles.
Zennou V, Perez-Caballero D, Göttlinger H, Bieniasz PD.
J Virol. 2004 Nov;78(21):12058-61.
APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.
Burnett A, Spearman P.
J Virol. 2007 May;81(10):5000-13. Epub 2007 Mar 7.
Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase.
Nowarski R, Britan-Rosich E, Shiloach T, Kotler M.
Nat Struct Mol Biol. 2008 Oct;15(10):1059-66. Epub 2008 Sep 28.
Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H.
Soros VB, Yonemoto W, Greene WC.
PLoS Pathog. 2007 Feb;3(2):e15.
RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.
Bernacchi S, Henriet S, Dumas P, Paillart JC, Marquet R.
J Biol Chem. 2007 Sep 7;282(36):26361-8. Epub 2007 Jul 2.
Single-stranded RNA facilitates nucleocapsid: APOBEC3G complex formation.
Bogerd HP, Cullen BR.
RNA. 2008 Jun;14(6):1228-36. Epub 2008 May 2.
RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.
Huthoff H, Autore F, Gallois-Montbrun S, Fraternali F, Malim MH.
PLoS Pathog. 2009 Mar;5(3):e1000330. Epub 2009 Mar 6.
Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant.
Opi S, Kao S, Goila-Gaur R, Khan MA, Miyagi E, Takeuchi H, Strebel K.
J Virol. 2007 Aug;81(15):8236-46. Epub 2007 May 23.
Differential sensitivity of "old" versus "new" APOBEC3G to human immunodeficiency virus type 1 vif.
Goila-Gaur R, Khan MA, Miyagi E, Strebel K.
J Virol. 2009 Jan;83(2):1156-60. Epub 2008 Nov 12.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on